ALSPW Spineway SA
Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The company was incorporated in 2005 and is headquartered in Ecully, France.…
Industry Peers
Medical Instruments & SuppliesKey Statistics
About Spineway (EPA: ALSPW)
›
Spineway (EPA: ALSPW) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 46 employees.
The shares were at 0.0930 EUR on 19 November 2026, down 43.6% over 52 weeks. Its 52-week range is 0.0816 EUR to 0.2110 EUR: the price is 55.9% below the high and 14.0% above the low.
Its market capitalisation is 3.31M EUR.
Spineway reports return on equity of -9.7%, an operating margin of -20.1% and revenue up 5.5% year over year.
Its debt exceeds its cash by 62.00K EUR, a debt-to-equity ratio of 0.07. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. One analyst covers the stock; their mean price target of 0.2100 EUR is 125.8% above the current price.